Arno Hartmann
Director/Board Member at BioVascular, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John H. Parrish | M | - |
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | 19 years |
| Stuart J. M. Collinson | M | 64 |
Tioga Pharmaceuticals, Inc.
 Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | 19 years |
| Paul F. Glidden | M | - |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | 19 years |
| Alison J. Pilgrim | M | - |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | - |
| Martin C. Münchbach | M | 54 |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA.
Tioga Pharmaceuticals, Inc.
Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | 19 years |
| Brian H. Dovey | M | 83 |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | - |
| James Niedel | M | 79 |
Tioga Pharmaceuticals, Inc.
Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | - |
| Stephen R. Hanson | M | - |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | - |
| Christopher M. Bussineau | M | - |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andreas Horst Düsterhöft | M | 63 |
University of Giessen
| 8 years |
| Angelika Vlachou | M | - |
University of Giessen
| 10 years |
| Markus Stillger | M | 62 |
University of Giessen
| 3 years |
| Susanne Fuchs | M | 60 |
University of Giessen
| 3 years |
| Ingo Weber | M | - |
University of Giessen
| 4 years |
| Ralf Guckert | M | 58 |
University of Giessen
| 6 years |
| Stefan Thies | M | - |
University of Giessen
| 5 years |
| Joachim Gläser | M | 56 |
University of Giessen
| 3 years |
| Hubertus Troska | M | 64 |
University of Giessen
| 4 years |
| Gerd Wingefeld | M | 66 |
University of Giessen
| 3 years |
| Mechthild Auge | M | 66 |
University of Giessen
| 4 years |
| Dieter Meuser | M | - |
University of Giessen
| - |
| Holger Kowarsch | M | 55 |
University of Giessen
| 6 years |
| Markus Scheer | M | 63 |
University of Giessen
| 4 years |
| Michael Rüdiger | M | 60 |
University of Giessen
| 4 years |
| Robert Latka | M | 58 |
University of Giessen
| 4 years |
| Frank Alexander Rothauge | M | 55 |
University of Giessen
| 5 years |
| Jörg Schönewolf | M | - |
University of Giessen
| 4 years |
| Hermann Melnikov | M | - |
University of Giessen
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 19 | 67.86% |
| United States | 9 | 32.14% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Arno Hartmann
- Personal Network
